Cervical Intraepithelial Neoplasia News and Research

RSS

HPV vaccination linked to sharp decline in cervical cancer deaths

High-income countries that initiated widespread administration of the Human Papilloma Virus (HPV) vaccine in the mid-2000s have experienced substantial declines in cervical cancer cases, marking a significant achievement in medicine.

18 Jun 2026

Personalized counseling program helps cervical cancer survivors quit smoking

A new study led by UCLA researchers suggests that a personalized counseling program can significantly help women who have survived cervical precancer or cervical cancer to quit smoking - and does so at a cost that researchers say represents good value for healthcare systems.

12 Mar 2026

Menstrual blood HPV testing accurately detects cervical precancer

A study reveals menstrual blood can effectively screen for HPV, matching clinician-collected samples in accuracy, enhancing cervical cancer detection globally.

9 Feb 2026

New federal guidelines shift cervical cancer screening to HPV testing

New cervical cancer screening guidelines emphasize self-collection and hrHPV testing, aiming to increase screening rates and improve women's health outcomes.

8 Jan 2026

HPV16 vaccine shows promise in treating precancerous cervical lesions

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

24 Jan 2025

Cervical mucus biomarkers could improve early detection of cervical cancer

Cervical cancer is a highly prevalent cancer, with approximately 500,000 new cases diagnosed each year.

5 Aug 2024

New urine-based test holds great promise for early detection and prevention of cervical cancer

Cervical cancer is one of the most common cancers in women, with approximately 660,000 new cases and 350,000 deaths worldwide in 2022 alone.

8 Jul 2024

Study shows safety of extended HPV testing intervals in cervical cancer screening

The risk of detecting cervical precancer eight years after a negative human papillomavirus (HPV) screening was found to be similar to the risk after three years (the commonly recommended screening interval) after a negative cytology screening.

22 May 2024

HPV vaccination reduces cervical cancer across all socioeconomic groups in England

The human papillomavirus (HPV) vaccination programme in England has not only been associated with a substantial reduction in cervical disease, but has done so in all socioeconomic groups, finds a study published by The BMJ today.

16 May 2024

Cervical cancer rates drop significantly among vaccinated women

The efficiency of the HPV vaccination program in reducing the prevalence of cervical cancers.

16 May 2024

New cervical cancer detection method promises to reduce unnecessary screenings

The BMC Medicine study introduces the CerMe detection method, using PCDHGB7 hypermethylation to effectively triage high-risk HPV-positive women, potentially reducing unnecessary colposcopy referrals.

8 Feb 2024

Study models advantages, harms, and affordability of WHO proposed cervical cancer screening strategies for women in LMICs

The harms, benefits, and affordability of seven primary screening algorithms for human papillomavirus (HPV).

14 Dec 2023

Active surveillance for cervical precancer lesions linked to increased long-term cancer risk

Actively monitoring abnormal cells (lesions) that line the cervix rather than removing them straight away is associated with an increased long term risk of cervical cancer, suggests a study published by The BMJ today.

29 Nov 2023

Promising new cervical cancer test fills in the gap missed by Pap tests

Researchers assessed a novel human papillomavirus (HPV) and host deoxyribonucleic acid (DNA) methylation score for adenocarcinoma in-situ (AIS) and cervical adenocarcinoma (ADC) screening.

8 Sep 2023

SARS-CoV-2 infection can affect menstruation

Researchers assess the association between SARS-CoV-2 infection and menstrual irregularities.

30 Oct 2022

HPV vaccine together with surgical treatment for cervical lesions may reduce recurrence of preinvasive disease

Giving women the human papillomavirus (HPV) vaccine around the time they have surgery for precancerous cervical lesions might lead to a reduction in the risk of lesions returning as well as other HPV-related diseases, suggests a study published by The BMJ today.

4 Aug 2022

NCCN publishes new guidelines to help cervical cancer patients become more informed about care

The National Comprehensive Cancer Network has published new NCCN Guidelines for Patients: Cervical Cancer to help people with cervical cancer become more informed, suggest what conversations to have with their doctor, and be active decision makers in their treatment.

13 Dec 2021

Cervical Intraepithelial Neoplasia News and Research

HPV vaccination linked to sharp decline in cervical cancer deaths

Personalized counseling program helps cervical cancer survivors quit smoking

Menstrual blood HPV testing accurately detects cervical precancer

New federal guidelines shift cervical cancer screening to HPV testing

HPV16 vaccine shows promise in treating precancerous cervical lesions

Cervical mucus biomarkers could improve early detection of cervical cancer

New urine-based test holds great promise for early detection and prevention of cervical cancer

Study shows safety of extended HPV testing intervals in cervical cancer screening

HPV vaccination reduces cervical cancer across all socioeconomic groups in England

Cervical cancer rates drop significantly among vaccinated women

New cervical cancer detection method promises to reduce unnecessary screenings

Study models advantages, harms, and affordability of WHO proposed cervical cancer screening strategies for women in LMICs

Active surveillance for cervical precancer lesions linked to increased long-term cancer risk

Promising new cervical cancer test fills in the gap missed by Pap tests

SARS-CoV-2 infection can affect menstruation

HPV vaccine together with surgical treatment for cervical lesions may reduce recurrence of preinvasive disease

NCCN publishes new guidelines to help cervical cancer patients become more informed about care

Dramatic reduction in cervical cancer in the UK following the introduction of HPV vaccination

COVID-19-related disruptions to cervical cancer screening could increase risk sevenfold, UK case study finds

HPV vaccination reduces risk of cervical cancer

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News